Tag: Aduhelm

Cropped shot of a female nurse hold her senior patient's hand

The Food and Drug Administration recently granted fast-track approval to a new Alzheimer’s drug designed to slow the rate of cognitive decline for individuals in the early stages of the disease.  The drug, which will be sold under the brand name Leqembi, was developed jointly by Eisai and Biogen – the same two companies that…

Stethoscope with medicare form with parts list.

The brief’s key findings are: Medicare’s finances have improved over the past decade, but major challenges remain, such as the program’s vulnerability to expensive new drugs. This risk was underscored by the saga of Aduhelm, a costly and controversial new drug for early-stage Alzheimer’s. The immediate risk eased in January when Medicare proposed limiting t…